InvestorsHub Logo
Followers 0
Posts 994
Boards Moderated 0
Alias Born 06/03/2015

Re: rafunrafun post# 56789

Tuesday, 08/18/2015 10:09:05 AM

Tuesday, August 18, 2015 10:09:05 AM

Post# of 425930
No, Watson appeal has nothing to do with the FDA leaving Amarin exclusivity as "No expired exclusivity". IMO Amarin will not be assigned exclusivity until after REDUCE-IT. If the exclusivity committee could agree on NCE for Marine it would have happened. For the FDA they want the results of REDUCE-IT. NME wasn't an exceptable Regulatory scheme according to Judge Moss. "No expired exclusivity" can be left until FDA has the information to make an appropriate decision.

BB

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News